Dr. Shashank Joshi retweetledi

The weight loss independent actions of GLP-1 medicines continue to surprise. The next chapter, focused on #MASH drops this Tuesday
Scott Isaacs@scottisaacsmd
New review by Maria Gonzalez-Rellan & Daniel Drucker focuses on the expanding benefits of GLP-1 meds like semaglutide & tirzepatide. Beyond glucose/weight control: ↓ CVD events, CKD progression, MASLD, OA, sleep apnea (via anti-inflammatory paths) partly weight-loss independent. cell.com/cell-reports-m…
English



























